LDOS vs LFCR · P/E 16, rev $8.96B vs rev $75.5M
Leidos Holdings Inc (LDOS) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
LDOS currently screens at market cap $20.04B and trailing P/E 15.7. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the LDOS and LFCR stock pages for the full models.
Not investment advice.